<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
    	<title>IJPRS/V2/I3/00133 - 02/09/2013</title>

	<item>
		<title>Sucralfate Suspension Reduced Absorption of Oral Ciprofloxacin Hydrochloride in Rabbit</title>
		
		<description><![CDATA[<h5>Author's Affiliation</h5>
		                                                <p></p>
		                                                <hr/>
                                                    	<h5>Abstract</h5>
		                                                <p>One of the most frequent side effects due to the use of ciprofloxacin is a gastrointestinal disorder. Generally, in order to overcome the side effects of the Gastro Intestinal Track (GIT), the drug is given after meals (provided 15-30 minutes after meals). Unfortunately the present of food in gaster can significantly decrease maximum concentration (C<sub>max</sub>) of ciprofloxacin. The aim of this study was to determine the effect of sucralfate suspension that containing alumunium (Al<sup>3+</sup>) on the absorption of oral ciprofloxacin HCl. The effects of 0.47 mL/kg body weight doses of sucralfate suspension which is containing polyvalent cations, aluminum sucrose octa sulfate on the absorption of oral ciprofloxacin HCl before a single 23 mg/kg body weight doses were investigated in 6 rabbit subjects, randomized, cross over and single blind study. The 6 rabbits were enrolled in two studies. Each subject got single ciprofloxacin HCl administration as a control treatment. Treatments that were evaluated included the administration of sucralfate with single dose of ciprofloxacin HCl concomitantly (treatment 1) and the administration of sucralfate 2 hours before ciprofloxacin HCl administration (treatment 2). The absorption parameters of ciprofloxacin HCl were determined by spectrofluorometric method using time to reach maximum concentration (t<sub>max</sub>), C<sub>max</sub> and area under curve (AUC) parameters. In control treatment, the average value of C<sub>max</sub>, t<sub>max</sub>, and AUC<sub>0-360</sub> were 1.34 µg/mL ± 26.15%, 160.78 minutes ± 5.85% and 337.06 µg minutes/mL ± 14.40%. In treatment 1, the average value of C<sub>max</sub>, t<sub>max</sub>, and AUC<sub>0-360</sub> were 0.68 µg/mL ± 15.49%, 420.66 minutes ± 25.49% and 277.13 µg.minutes/mL ± 12.25%, and in treatment 2 were 0.95 µg/mL ± 18.54%, 284.93 minutes ± 15.44% and 309.75 µg.minutes/mL ± 11.71%. Statistical analysis used in this study was one-sided paired t test (α = 0.05). On the basis of these findings, ciprofloxacin HCl and sucralfate should not be administered concomitantly, but normal kinetics are restored by administering the drug 2 hours before ciprofloxacin HCl. <em>Andrographis paniculata</em> extract suppressed cancer cell growth by decreased cell proliferation and increased apoptosis.</p>
                                                    	<hr/>
                                                        <h5>Keywords</h5>
                                                         <p>Ciprofloxacin, Sucralfate, Spectrofluorometric, Interaction of Fluoroquinolone</p>
                                                         
                                                    	                                                    	<hr/>
                                                         <h5>Cite This Article</h5>
                                                         <p>Hariadini, A. L., Aryani, T., Suharjono. (2013). Sucralfate Suspension Reduced Absorption of Oral Ciprofloxacin Hydrochloride in Rabbit. <em>International Journal for Pharmaceutical Research Scholars (IJPRS), 2(3),</em> 202-209.</p>                                                         <hr/>
                                                         <p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fsucralfate-suspension-reduced-absorption-of-oral-ciprofloxacin-hydrochloride-in-rabbit%2F&amp;linkname=Sucralfate%20Suspension%20Reduced%20Absorption%20of%20Oral%20Ciprofloxacin%20Hydrochloride%20in%20Rabbit" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fsucralfate-suspension-reduced-absorption-of-oral-ciprofloxacin-hydrochloride-in-rabbit%2F&amp;linkname=Sucralfate%20Suspension%20Reduced%20Absorption%20of%20Oral%20Ciprofloxacin%20Hydrochloride%20in%20Rabbit" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fsucralfate-suspension-reduced-absorption-of-oral-ciprofloxacin-hydrochloride-in-rabbit%2F&#038;title=Sucralfate%20Suspension%20Reduced%20Absorption%20of%20Oral%20Ciprofloxacin%20Hydrochloride%20in%20Rabbit" data-a2a-url="https://www.ijprs.com/article/sucralfate-suspension-reduced-absorption-of-oral-ciprofloxacin-hydrochloride-in-rabbit/" data-a2a-title="Sucralfate Suspension Reduced Absorption of Oral Ciprofloxacin Hydrochloride in Rabbit"></a></p>]]>
        </description>
		<link>https://www.ijprs.com/article/sucralfate-suspension-reduced-absorption-of-oral-ciprofloxacin-hydrochloride-in-rabbit/</link>
		<author>Hariadini, A. L., Aryani, T., Suharjono        </author>

		<pdflink>http://www.ijprs.com/wp-content/uploads/2018/09/IJPRS-V2-I3-00133.pdf</pdflink>

	</item>
</channel>
</rss>
